EquityBulls

Latest News

Keywords Selected: INE049B01025

Stock Report

Leading U.K. Medical Journal publishes a Complex Case of Severe Pandrug Resistant Infection in U.S. Liver Transplant Patient Successfully Treated with Zaynich®
Wockhardt initiates strategic realignment of US Operations to focus on Innovative Portfolio
Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with Zaynich™
Zaynich™ enables US cancer patient undergo successful liver transplant and resume chemotherapy by eradicating dual extreme drug resistant Gram negative pathogens
Wockhardt files fast-acting Insulin Aspart injection with DCGI
Wockhardt's yet another novel antibiotic Miqnaf™ receives favourable recommendation from Subject Expert Committee of CDSCO for the Treatment of CABP
Dr. Habil Khorakiwala bestowed Lifetime Achievement Award by Integrated Health and Wellbeing Council in Dubai
Wockhardt's Investigational Drug, Zaynich™ cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use
Wockhardt wins prestigious Innovator Award from Government of India
Globally renowned US body CLSI awards high susceptibility breakpoints to Zaynich
Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873
Ind-Ra revises ratings of Wockhardt Ltd
Wockhardt promoters sell stake, reinvest proceeds in the company
Wockhardt Ltd closes Illinois manufacturing facility
Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222
Wockhardt Ltd allots 3,32,44,650 Equity Shares
Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in UK
NIH, USA to conduct human Phase 1 trial of Wockhardt's novel once-a-day MDR Gram-negative antibiotic WCK 6777
Wockhardt Limited announces 3:10 rights issue at Rs. 225 per share
Wockhardt to consider rights issue terms and conditions on March 3, 2022
Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines
Wockhardt Limited board approves rights issue to raise Rs. 1000 crore
Wockhardt Limited board to consider fund raising options on Jan 6, 2022